As used herein, the term “pharmaceutically acceptable” indicates that the indicated material does not have properties that would cause a reasonably prudent medical practitioner to avoid administration of the material to a patient, taking into consideration the disease or conditions to be treated and ...
[UCLA standard data access language] The research team, authorized UCLA personnel, the study sponsor [remove if not applicable], the National Cancer Institute (NCI) and regulatory agencies such as the Food and Drug Administration (FDA), may have access to study data and records to monitor the...